AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 100 filers reported holding AVROBIO INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $973,000 | -41.1% | 109,460 | -16.0% | 0.00% | -50.0% |
| Q1 2021 | $1,653,000 | +20.3% | 130,270 | +32.2% | 0.00% | 0.0% |
| Q4 2020 | $1,374,000 | -9.4% | 98,550 | -15.3% | 0.00% | 0.0% |
| Q3 2020 | $1,516,000 | -44.1% | 116,420 | -25.1% | 0.00% | -50.0% |
| Q2 2020 | $2,713,000 | -80.0% | 155,503 | -82.1% | 0.00% | -63.6% |
| Q1 2020 | $13,532,000 | +61.0% | 869,666 | +108.3% | 0.01% | +10.0% |
| Q4 2019 | $8,405,000 | +23.9% | 417,549 | -13.1% | 0.01% | +11.1% |
| Q3 2019 | $6,784,000 | +268.9% | 480,429 | +324.9% | 0.01% | +125.0% |
| Q2 2019 | $1,839,000 | -39.0% | 113,071 | -17.3% | 0.00% | -42.9% |
| Q1 2019 | $3,016,000 | +6183.3% | 136,761 | +4614.3% | 0.01% | – |
| Q4 2018 | $48,000 | -73.2% | 2,901 | -16.0% | 0.00% | – |
| Q3 2018 | $179,000 | +108.1% | 3,454 | +15.1% | 0.00% | – |
| Q2 2018 | $86,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 4,001,627 | $6,162,506 | 5.66% |
| Vazirani Asset Management LLC | 468,273 | $721,140 | 1.10% |
| Atlas Venture Life Science Advisors, LLC | 4,541,381 | $6,993,727 | 1.08% |
| Terrapin Asset Management, LLC | 558,787 | $860,532 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 3,512,686 | $5,409,536 | 0.76% |
| Newtyn Management, LLC | 2,000,000 | $3,080,000 | 0.76% |
| Aldebaran Capital, LLC | 470,130 | $724,000 | 0.74% |
| Aisling Capital Management LP | 1,009,779 | $1,555,060 | 0.64% |
| Western Standard LLC | 310,361 | $477,956 | 0.43% |
| Affinity Asset Advisors, LLC | 500,000 | $770,000 | 0.22% |